View More Recent Stories

May 13, 2019 07:00AM Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
May 13, 2019 07:00AM Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
Apr 25, 2019 08:00AM Cyclerion to Host Corporate Overview Call on May 13, 2019
Apr 25, 2019 08:00AM Cyclerion to Host Corporate Overview Call on May 13, 2019
Apr 9, 2019 08:00AM Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
Apr 9, 2019 08:00AM Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
Apr 2, 2019 08:00AM Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases
Apr 2, 2019 08:00AM Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases
Apr 1, 2019 04:02PM Ironwood Pharmaceuticals Completes Separation of Cyclerion Therapeutics and Becomes a Gastrointestinal (GI)-focused Healthcare Company
View More Recent Stories